Migraine Tracker | Aimovig (erenumab-aooe)

Track your migraine with a daily text

This migraine tracking tool is a quick, easy way to track your migraine. It will help you recognize patterns and changes in a monthly email report. All you have to do is:

Respond to a daily text
Review your monthly report, which will be emailed to you in a calendar format

Tracking your migraine gives you and your doctor important information, which can help you both create a migraine management plan that’s specific to your needs. If you’re ready to start tracking, sign up below!

Have questions? Download the migraine tracker FAQ (PDF).

Before we start, do you have a prescription for Aimovig^® (erenumab-aooe)?

Yes No

Sign up for the tracker

*Required information

*First Name

*Last Name

You must be 18 years or older to enroll in Aimovig Digital (SMS) Migraine Tracker.

*Date of Birth

*Email Address

*Zip Code

*Mobile Phone Number (Message and data rates may apply)

*Date when you will take your next dose of Aimovig^®

Program Details

To join Aimovig’s Migraine program go to www.aimovig.com/migrainetracker or call 1-833-246-6844 to register. Fill in the required information including your mobile number and email address. You will receive an opt-in request from the short code. After you reply with the keyword START you will receive a confirmation message and be opted into the program.

You will receive recurring questions and alerts. Reply HELP to 43109 for help, STOP to 43109 to cancel. Message and Data Rates May Apply.

TO OPT-IN TO THE SERVICE ON 43109:

Fill out the registration form at www.aimovig.com/migrainetracker. Reply START to the message you receive.

RESPONSE FROM 43109:

Thanks! You’ll start receiving daily texts tomorrow. Msg&Data rates may apply. Reply HELP for help. Reply STOP to cancel.

To STOP (OPT-OUT OF) THE SERVICE ON 43109:

You can cancel receipt of all SMS messages from 43109 by replying to any service message, or sending ‘STOP’ to 43109.

STOP RESPONSE:

Thanks for tracking. You’ll no longer receive texts for your migraine tracker.

TO GET HELP ON THE SERVICE ON 43109:

You can get HELP, by replying to any service message, or sending ‘HELP’ to 43109.

HELP RESPONSE:

Questions about your migraine tracker? Call 833-246-6844. Reply MMD at any time for the migraine day definition. Reply STOP to cancel.

Consents

Step 1 of 3

*Please make a selection

Consent to Health Data Processing for Aimovig Digital (SMS) Migraine Tracker

I consent to Amgen processing my Health Data for the following purposes:

To enroll me and manage my participation in Amgen’s Aimovig Digital (SMS) Migraine Tracker program, which includes activities related to my condition or treatment (for example, co-pay card programs, payer medication coverage verification, nurse partner support, disease management support), and to manage Amgen’s products, services, and programs related to my condition or treatment.

Amgen uses the following when it administers the Aimovig Digital (SMS) Migraine Tracker program:

Health Data – my name (and the name of my caregiver if applicable), gender, date of birth, contact information and information relating to my health condition or treatment.

I understand that my consent to processing is required for me to participate in the Aimovig Digital (SMS) Migraine Tracker program. I also understand that Amgen will not sell my Health Data to third parties, but Amgen may disclose my Health Data to Amgen’s data processors, contractors, and business partners for Amgen’s business purposes related to the Aimovig Digital (SMS) Migraine Tracker program. I understand that Amgen may use my Health Data to contact me by mail, email, telephone, or text for the above purposes. I also understand that if I do not consent to the use of my Health Data for the above purposes, I will not be able to participate in the Aimovig Digital (SMS) Migraine Tracker program. Finally, I understand that I may withdraw my consent to processing my Health Data for the above purposes at any time using one of the methods listed in the Additional Disclosures section below and that if I withdraw my consent, I will no longer be able to participate in the Aimovig Digital (SMS) Migraine Tracker program.

I consent to the collection, processing, and disclosure of my Health Data for the above purposes I do not consent to the collection, processing, or disclosure of my Health Data for the above purposes By selecting “I do not consent to the collection, processing, or disclosure of my Health Data for the above purposes,” you will not be able to continue enrolling in Aimovig Digital (SMS) Migraine Tracker By selecting “I do not consent to the collection, processing, or disclosure of my Health Data for the above purposes,” you will not be able to continue enrolling in Aimovig Digital (SMS) Migraine Tracker

Step 2 of 3

*Please make a selection

Consent to Health Data Collection & Processing for Marketing Purposes

I consent to Amgen collecting and processing my Health Data for the following purposes:

To conduct marketing activities, including market research activities, and to communicate with me regarding products and services that may be of interest to me.

Amgen uses the following for marketing purposes:

Health Data – my name, gender, date of birth, contact information and information relating to my health condition or treatment.

I understand that Amgen is seeking my consent to collect and process my Health Data to market products and services to me and that I do not have to give consent to the collection and processing of my Health Data for marketing purposes in order to participate in the Aimovig Digital (SMS) Migraine Tracker program. I also understand that Amgen will not sell my Health Data to third parties. If I consent to the collection and processing of my Health Data for marketing purposes, I agree that Amgen may contact me for marketing purposes. Finally, I understand that I may withdraw my consent to the collection and processing of my Health Data for marketing purposes at any time using one of the methods listed in the Additional Disclosures section below.

I consent to the collection and processing of my Health Data for marketing purposes I do not consent to the collection and processing of my Health Data for marketing purposes If you do not consent to the collection and processing of your health data for marketing purposes, you will not be able to receive marketing communications from Amgen. If you want to receive marketing communications from Amgen, select “I consent to the collection and processing of my Health Data for marketing purposes” If you do not consent to the collection and processing of your health data for marketing purposes, you will not be able to receive marketing communications from Amgen. If you want to receive marketing communications from Amgen, select “I consent to the collection and processing of my Health Data for marketing purposes”

Step 3 of 3

*Please make a selection

Consent to Health Data Disclosure for Marketing Purposes

I consent to Amgen disclosing my Health Data to its data processors, contractors, and business partners for the following purposes:

To conduct marketing activities, including market research activities, and to communicate with me regarding products and services that may be of interest to me.

If I provide my consent, Amgen will disclose the following for such purposes:

Health Data – my name, gender, date of birth, contact information and information relating to my health condition or treatment.

I understand that Amgen is seeking my consent to disclose my Health Data to its data processors, contractors, and business partners to market products and services to me and that I do not have to give consent to disclosure of my Health Data for marketing purposes in order to participate in Aimovig Digital (SMS) Migraine Tracker. I also understand that Amgen will not sell my Health Data to third parties. Finally, I understand that I may withdraw my consent to the disclosure of my Health Data for marketing purposes at any time using one of the methods listed in the Additional Disclosures section below.

I consent to the disclosure of my Health Data for marketing purposes I do not consent to the disclosure of my Health Data for marketing purposes If you do not consent to the disclosure of your health data for marketing purposes, you will not be able to receive marketing communications from Amgen. If you want to receive marketing communications from Amgen, select “I consent to the disclosure of my Health Data for marketing purposes” If you do not consent to the disclosure of your health data for marketing purposes, you will not be able to receive marketing communications from Amgen. If you want to receive marketing communications from Amgen, select “I consent to the disclosure of my Health Data for marketing purposes”

Additional Disclosures

I understand that participation in the Aimovig Digital (SMS) Migraine Tracker program and, if I have consented, receipt of marketing communications are optional services at no cost to me. The consent(s) above in no way affects my right to obtain any medications and I do not have to provide consent to be able to receive any medications. To obtain a copy of the consent(s) above or to withdraw my consent to collection, processing, and/or disclosure of my Health Data for any of the above purposes to which I have consented, I can contact Amgen by visiting www.amgen.com/DataSubjectRights or calling 1-833-246-6844. For more information about Amgen’s privacy practices, Amgen’s Privacy Statement can be found at http://www.amgen.com/privacy.

By clicking "Submit" you are agreeing to the Mobile Terms and Conditions, Privacy Policy, Terms of Use.

*I accept

Success!
You’re signed up!

So, what’s next? You’ll receive a text message about the migraine tracker that will just need a quick response. Then you’ll be officially enrolled!

The next day, you’ll start receiving a daily text at 8pm to track your migraine. And at the end of the month, a report will be emailed to you based on your daily responses.

Also, if you haven't already, stay in touch and connect with our community on Facebook and Instagram.

Thank you
for signing up.